An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia

Overview

This study is aimed to collect the following Serbia-specific epidemiology data on hypercholesterolemia: patents characteristics, patients' management/treatment and physicians' standard practice. In addition, the aim is to determine the proportion of patients on lipid-lowering pharmacological treatment who have reached the LDL-C and HDL-C treatment goals.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: October 2011

Arms, Groups and Cohorts

  • 1
    • Patients with hypercholesterolemia

Clinical Trial Outcome Measures

Primary Measures

  • Proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the NCEP ATP III / updated 2004 NCEP ATP III guidelines
    • Time Frame: 24 weeks

Secondary Measures

  • Proportion of patients on lipid-lowering pharmacological treatment reaching the non HDL-C goals according to the NCEP ATP III / updated 2004 NCEP ATP III guidelines;
    • Time Frame: 24 weeks
  • Physicians’ standard practice in managing patients with hypercholesterolemia (by using physicians’ questionnaire);
    • Time Frame: 24 weeks
  • Local epidemiological date on patients with hypercholesterolemia (Demographic Data; Hypercholesterolemia management data: treatment, treatment changes)
    • Time Frame: 24 weeks

Participating in This Clinical Trial

Inclusion Criteria

  • Patients with hypercholesterolemia currently receiving a lipid lowering agent Exclusion Criteria:

  • Pregnancy and lactation.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • AstraZeneca
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Prof.Dr Miodrag Ostojic, Principal Investigator, Division of Cardiology-Clinical Centre of Serbia-Belgrade

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.